Natural Beauty Bio Technology : FURTHER DELAY IN DESPATCH OF CIRCULAR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Natural Beauty Bio-Technology Limited

自然美生物科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 00157)

FURTHER DELAY IN DESPATCH OF CIRCULAR

Reference is made to (i) the announcement of the Company dated 23 July 2020 in relation to the Supplemental Agreements, 2020 CCT Agreement and the Transfer of Spa Business Agreement;

1. the announcement of the Company dated 12 August 2020 in relation to delay in despatch of circular in respect of the Supplemental Agreements, 2020 CCT Agreement and the Transfer of Spa Business Agreement; and (iii) the announcement of the Company dated 25 August 2020 in relation to, among other things, further delay in despatch of circular in respect of the Supplemental Agreements, 2020 CCT Agreement and the Transfer of Spa Business Agreement ("Announcement"). Unless otherwise stated, capitalised terms used herein shall have the same meanings as those defined in the Announcement.

As stated in the Announcement, a circular (the "Circular") containing, among other things, further details of the Supplemental Agreements, the 2020 CCT Agreements and Transfer of Spa Business Agreement, the respective advice of the Independent Financial Adviser and the Independent Board Committee and the notice of the EGM was expected to be despatched to the Shareholders on or before 9 September 2020.

As additional time is required for the Company to prepare and finalise certain information to be included in the Circular, it is expected that the date of despatch of the Circular and the notice of the EGM will be postponed to a date falling on or before 23 September 2020.

- 1 -

CONTINUED SUSPENSION OF TRADING

Trading in the Shares on the Stock Exchange has been suspended at the request of the Company since 9:00 a.m. on 25 March 2020 and will remain suspended until further notice. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.

By order of the Board

Natural Beauty Bio-Technology Limited

LEI Chien

Chairperson

Hong Kong, 9 September 2020

As at the date of this announcement, the Board comprises Dr. Lei Chien and Mr. Pan Yi-Fan as executive directors; Ms. Lu Yu-Min, Ms. Lin Shu-Hua and Mr. Chen Shou-Huang as non- executive directors; and Mr. Chen Ruey-Long, Mr. Lu Chi-Chant and Mr. Yang Shih-Chien as independent non-executive directors.

- 2 -